These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20227298)

  • 1. Medical management in peripheral arterial disease: a systematic approach to medical therapy.
    Goei AD; Findeiss LK; Slim AM
    J Vasc Interv Radiol; 2010 May; 21(5):603-5; quiz 606. PubMed ID: 20227298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
    Ferreira AC; Macedo FY
    Ann Med; 2010 Mar; 42(2):139-50. PubMed ID: 20156042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid lowering treatment of patients with atherosclerotic disease of the lower extremities].
    Bismuth J; Kofoed SC; Sillesen HH
    Ugeskr Laeger; 2001 Dec; 163(49):6882-5. PubMed ID: 11766498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral arterial disease is only the tip of the atherosclerotic "iceberg".
    Futterman LG; Lemberg L
    Am J Crit Care; 2002 Jul; 11(4):390-4. PubMed ID: 12102440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood lipid derangement common in peripheral artery disease. Lipid-lowering agents may alleviate symptoms and slow the atherosclerotic process].
    Bröijersén A; Wiklund B; Angelin B
    Lakartidningen; 2001 Sep; 98(36):3788-93. PubMed ID: 11586809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease undergoing surgery [corrected].
    Aldawood AS; Jaeschke R
    Saudi Med J; 2002 May; 23(5):585-8. PubMed ID: 12070587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
    Cavendish JJ; Safani M
    Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy insight: peripheral arterial disease and diabetes--from pathogenesis to treatment guidelines.
    Mohler ER
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):151-62. PubMed ID: 17330127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)].
    Béraut E; Cambou JP; Guilhem JM; Vaysse N; Labro S; Séverac D; Boccalon H; Bura-Rivière A
    J Mal Vasc; 2008 Feb; 33(1):1-11. PubMed ID: 18187280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral arterial disease. Medical management in primary care practice.
    Weiner SD; Reis ED; Kerstein MD
    Geriatrics; 2001 Apr; 56(4):20-2, 25-6, 29-30. PubMed ID: 11301719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral arterial disease: identification and implications.
    Mohler ER
    Arch Intern Med; 2003 Oct; 163(19):2306-14. PubMed ID: 14581250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of risk in peripheral artery disease: recent therapeutic advances.
    Hackam DG; Goodman SG; Anand SS
    Am Heart J; 2005 Jul; 150(1):35-40. PubMed ID: 16084148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The best of vascular medicine in 2006].
    Mounier-Vehier C; Stephan D; Aboyans V; Beregi JP; Lacroix P; Léger P; Long A; Sevestre MA;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():47-55. PubMed ID: 17405565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.